dc.contributor.author | Dufton Mwaengo | |
dc.contributor.author | Ushanandini Mohanraj | |
dc.contributor.author | Maria Söderlund-Venermo | |
dc.contributor.author | Klaus Hedman | |
dc.contributor.author | Moses Masika | |
dc.contributor.author | Paula M. Kinnunen1 | |
dc.contributor.author | Haider Al-Hello | |
dc.contributor.author | Amir Majlesi | |
dc.contributor.author | Omu Anzala | |
dc.contributor.author | Ali M. Barakat | |
dc.contributor.author | Eric Delwart | |
dc.contributor.author | Olli Vapalahti | |
dc.contributor.author | Pikka Jokelainen | |
dc.contributor.author | Mohammadreza Sadeghi | |
dc.contributor.author | Farid A. Jalilian | |
dc.contributor.author | Elina Väisänen | |
dc.date.accessioned | 2022-10-28T14:31:13Z | |
dc.date.available | 2022-10-28T14:31:13Z | |
dc.identifier.uri | https://www.utupub.fi/handle/10024/171841 | |
dc.description.abstract | Development of next-generation sequencing and metagenomics has revolutionized detection of novel viruses. Among these viruses are 3 human protoparvoviruses: bufavirus, tusavirus, and cutavirus. These viruses have been detected in feces of children with diarrhea. In addition, cutavirus has been detected in skin biopsy specimens of cutaneous T-cell lymphoma patients in France and in 1 melanoma patient in Denmark. We studied seroprevalences of IgG against bufavirus, tusavirus, and cutavirus in various populations (n = 840), and found a striking geographic difference in prevalence of bufavirus IgG. Although prevalence was low in adult populations in Finland (1.9%) and the United States (3.6%), bufavirus IgG was highly prevalent in populations in Iraq (84.8%), Iran (56.1%), and Kenya (72.3%). Conversely, cutavirus IgG showed evenly low prevalences (0%-5.6%) in all cohorts, and tusavirus IgG was not detected. These results provide new insights on the global distribution and endemic areas of protoparvoviruses. | |
dc.language.iso | en | |
dc.publisher | CENTERS DISEASE CONTROL | |
dc.title | Global Distribution of Human Protoparvoviruses | |
dc.identifier.url | https://wwwnc.cdc.gov/eid/article/24/7/17-2128_article | |
dc.identifier.urn | URN:NBN:fi-fe2021042719451 | |
dc.relation.volume | 24 | |
dc.contributor.organization | fi=biolääketieteen laitos, yhteiset|en=Institute of Biomedicine| | |
dc.contributor.organization-code | 2607100 | |
dc.converis.publication-id | 32503927 | |
dc.converis.url | https://research.utu.fi/converis/portal/Publication/32503927 | |
dc.format.pagerange | 1292 | |
dc.format.pagerange | 1299 | |
dc.identifier.jour-issn | 1080-6040 | |
dc.okm.affiliatedauthor | Sadeghi, Mohammadreza | |
dc.okm.discipline | 3111 Biolääketieteet | fi_FI |
dc.okm.discipline | 3111 Biomedicine | en_GB |
dc.okm.internationalcopublication | international co-publication | |
dc.okm.internationality | International publication | |
dc.okm.type | Journal article | |
dc.relation.doi | 10.3201/eid2407.172128 | |
dc.relation.ispartofjournal | Emerging Infectious Diseases | |
dc.relation.issue | 7 | |
dc.year.issued | 2018 | |